These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19918671)

  • 1. Multigenerational Brazilian family with malignant hyperthermia and a novel mutation in the RYR1 gene.
    Matos AR; Sambuughin N; Rumjanek FD; Amoedo ND; Cunha LB; Zapata-Sudo G; Sudo RT
    Braz J Med Biol Res; 2009 Dec; 42(12):1218-24. PubMed ID: 19918671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-dimensional analysis of genotype-phenotype discordance in malignant hyperthermia susceptibility.
    Ibarra Moreno CA; Kraeva N; Zvaritch E; Figueroa L; Rios E; Biesecker L; Van Petegem F; Hopkins PM; Riazi S
    Br J Anaesth; 2020 Dec; 125(6):995-1001. PubMed ID: 32861507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.
    Klingler W; Heiderich S; Girard T; Gravino E; Heffron JJ; Johannsen S; Jurkat-Rott K; Rüffert H; Schuster F; Snoeck M; Sorrentino V; Tegazzin V; Lehmann-Horn F
    Orphanet J Rare Dis; 2014 Jan; 9():8. PubMed ID: 24433488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States.
    Brandom BW; Bina S; Wong CA; Wallace T; Visoiu M; Isackson PJ; Vladutiu GD; Sambuughin N; Muldoon SM
    Anesth Analg; 2013 May; 116(5):1078-1086. PubMed ID: 23558838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Malignant Hyperthermia Features in Patients with Pathogenic or Likely Pathogenic RYR1 Variants Disclosed through a Population Genomic Screening Program.
    Yu KD; Betts MN; Urban GM; Schwartz MLB; Robinson TO; Moyer RJ; Taddonio SW; Vasudevan A; Johns A; Sturm AC; Kelly MA; Williams MS; Poler SM; Buchanan AH
    Anesthesiology; 2024 Jan; 140(1):52-61. PubMed ID: 37787745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness.
    Fiszer D; Shaw MA; Fisher NA; Carr IM; Gupta PK; Watkins EJ; Roiz de Sa D; Kim JH; Hopkins PM
    Anesthesiology; 2015 May; 122(5):1033-46. PubMed ID: 25658027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calsequestrin-1: a new candidate gene for malignant hyperthermia and exertional/environmental heat stroke.
    Protasi F; Paolini C; Dainese M
    J Physiol; 2009 Jul; 587(Pt 13):3095-100. PubMed ID: 19417098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Association between OXPHOS-Related Gene Expression and Malignant Hyperthermia Susceptibility in Human Skeletal Muscle Biopsies.
    Chang L; Motley R; Daly CL; Diggle CP; Hopkins PM; Shaw MA
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families.
    Kim JH; Jarvik GP; Browning BL; Rajagopalan R; Gordon AS; Rieder MJ; Robertson PD; Nickerson DA; Fisher NA; Hopkins PM
    Anesthesiology; 2013 Nov; 119(5):1054-65. PubMed ID: 24013571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Remimazolam and Propofol on Ca
    Watanabe T; Miyoshi H; Noda Y; Narasaki S; Morio A; Toyota Y; Kimura H; Mukaida K; Yasuda T; Tsutsumi YM
    Biomed Res Int; 2021; 2021():8845129. PubMed ID: 33490280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian modeling to predict malignant hyperthermia susceptibility and pathogenicity of
    Sadhasivam S; Brandom BW; Henker RA; McAuliffe JJ
    Pharmacogenomics; 2019 Sep; 20(14):989-1003. PubMed ID: 31559918
    [No Abstract]   [Full Text] [Related]  

  • 12. Generation of two iPSC lines from patients with inherited central core disease and concurrent malignant hyperthermia caused by dominant missense variants in the RYR1 gene.
    Clayton JS; Vo C; Crane J; Scriba CK; Saker S; Larmonier T; Malfatti E; Romero NB; Ravenscroft G; Laing NG; Taylor RL
    Stem Cell Res; 2024 Jun; 77():103410. PubMed ID: 38583293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia: a review.
    Rosenberg H; Pollock N; Schiemann A; Bulger T; Stowell K
    Orphanet J Rare Dis; 2015 Aug; 10():93. PubMed ID: 26238698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue, depression, and physical activity in patients with malignant hyperthermia: a cross-sectional observational study.
    Andrade PMV; Valim LÍM; Santos JMD; Castro I; Amaral JLGD; Silva HCAD
    Braz J Anesthesiol; 2023; 73(2):132-137. PubMed ID: 34626754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remimazolam-based total intravenous anesthesia in a patient with a confirmed diagnosis of malignant hyperthermia: a case report.
    Kondo H; Mukaida K; Sasai K; Nao Y; Hashimoto K; Miyoshi H; Kanzaki R; Tsutsumi YM
    JA Clin Rep; 2024 Apr; 10(1):26. PubMed ID: 38647904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of guidelines to assess the risk of malignant hyperthermia in individuals with an RYR1 variant.
    Voermans NC; Yang C; Schouten M; Girard T; Stowell K; Riazi S; Kamsteeg EJ; Snoeck M
    Neuromuscul Disord; 2024 Feb; 35():40-41. PubMed ID: 38007345
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to: The use of guidelines to assess the risk of malignant hyperthermia in individuals with a RYR1 variant.
    Herdewyn S; De Bleecker J; Janssens L; Symoens S; Milazzo M; De Puydt J
    Neuromuscul Disord; 2024 Feb; 35():39. PubMed ID: 38237271
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiological and clinical features of malignant hyperthermia: A scoping review.
    Cong Z; Wan T; Wang J; Feng L; Cao C; Li Z; Wang X; Han Y; Zhou Y; Gao Y; Zhang J; Qu Y; Guo X
    Clin Genet; 2024 Mar; 105(3):233-242. PubMed ID: 38148504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Hyperthermia in Bariatric Surgery: A Case Study With Clinical, Pathophysiological, Biochemical and Biophysical Correlations.
    Oliveira PEA; Salvador GHM; Marchi-Salvador DP
    J Med Cases; 2020 Dec; 11(12):379-387. PubMed ID: 34434350
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.